Skip to content
LATEST
Health

Fish Oil Supplements Fail to Boost Brain Health Despite $1 Billion Market

A two-year clinical trial indicates that fish oil supplements fail to improve cognitive function or prevent brain shrinkage, despite successfully increasing…

Fish Oil Supplements Fail to Boost Brain Health Despite $1 Billion Market

A two-year clinical trial has determined that daily omega-3 supplementation fails to improve memory or prevent brain atrophy in older adults at risk for Alzheimer’s disease. While the study confirmed that 2,000 mg daily doses of docosahexaenoic acid () successfully increased omega-3 concentrations in cerebrospinal fluid by 17%, these physiological changes did not translate into measurable cognitive improvements.

The study, which tracked 365 participants aged 55 to 80, found no significant difference in cognitive performance or hippocampal volume between the treatment group and those receiving a placebo. Nearly half of the participants carried the APOE4 gene variant, a primary genetic risk factor for late-onset Alzheimer’s, yet the supplements provided no protective effect for this high-risk demographic.

These findings challenge the efficacy of a supplement market currently valued at over $1 billion annually in the United States. Researchers suggest that the isolated delivery of nutrients via supplements may not replicate the complex biological interactions provided by dietary intake, indicating a potential shift in clinical guidance regarding preventive brain health strategies.

More stories

Latest news